Preliminary results from the US Food and Drug Administration's (FDA's) mandated postmarket surveillance studies of duodenoscopes show "higher-than-expected" contamination rates after reprocessing, according to an article on the Medscape website.
The FDA said 3 percent of properly collected samples tested positive for more than 100 colony-forming units of "low-concern" organisms.
These organism are unlikely to cause serious infections but are, nevertheless, an indication of a "reprocessing failure."
An additional 3 percent of properly collected samples tested positive for "high-concern" bacteria that are more often associated with disease.
Upward Mobility: Market Forces Drive Hospitals Higher
Georgia Hospital Bomb Hoaxes Highlight Need for Healthcare–Police Partnerships
MUSC Health Celebrates Groundbreaking for Nexton Hospital and Ambulatory Cancer Facility
Mattresses Require Strict Care to Prevent Spread of Infections
Gardner Health Services Opens Alum Rock Health Center